REGENXBIO Inc. (RGNX)
USD 7.77
(-8.26%)
USD 7.77
(-8.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 90.24 Million | 112.72 Million | 470.34 Million | 154.56 Million | 35.23 Million | 218.5 Million |
| Cost of Revenue | 37.21 Million | 54.54 Million | 51.83 Million | 35.71 Million | 8.24 Million | 9.64 Million |
| Gross Profit | 53.02 Million | 58.17 Million | 418.51 Million | 118.85 Million | 26.99 Million | 208.86 Million |
| Operating Expenses | 321.15 Million | 321.05 Million | 258.53 Million | 238.08 Million | 175.99 Million | 120.76 Million |
| Selling, General and Administrative Expenses | 88.49 Million | 85.28 Million | 79.33 Million | 63.81 Million | 51.81 Million | 36.85 Million |
| Research and Development Expenses | 232.26 Million | 242.45 Million | 181.43 Million | 166.29 Million | 124.18 Million | 83.87 Million |
| Other Expenses | 397 Thousand | -6.67 Million | -2.23 Million | 7.97 Million | -10 Thousand | 42 Thousand |
| Cost and Expenses | 358.37 Million | 375.6 Million | 310.36 Million | 273.8 Million | 184.23 Million | 130.4 Million |
| Operating Income | -268.12 Million | -262.87 Million | 159.98 Million | -119.23 Million | -148.99 Million | 88.1 Million |
| Interest Expense | 6.86 Million | 23.25 Million | 26.27 Million | 771 Thousand | - | - |
| Income Tax Expense | -152 Thousand | -84 Thousand | 13.4 Million | 5.24 Million | -2.75 Million | 4.17 Million |
| Earnings before Tax | -263.64 Million | -280.4 Million | 141.24 Million | -106.01 Million | -97.48 Million | 104.11 Million |
| Net Income | -263.49 Million | -280.32 Million | 127.84 Million | -111.25 Million | -94.73 Million | 99.93 Million |
| Earnings Per Share Basic | -6.02 | -6.50 | 3.01 | -2.98 | -2.58 | 2.73 |
| Earnings Per Share Diluted | -6.02 | -6.50 | 2.91 | -2.98 | -2.58 | 2.73 |
| Weighted Average Shares Outstanding | 43.73 Million | 43.15 Million | 42.43 Million | 37.28 Million | 36.69 Million | 36.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.73 Million | 43.15 Million | 43.91 Million | 37.28 Million | 36.69 Million | 36.64 Million |
| Gross Margin | 0.59 | 0.52 | 0.89 | 0.77 | 0.77 | 0.96 |
| EBIT Margin | -2.65 | -2.33 | 0.34 | -0.74 | -5.61 | 0.37 |
| Profit Margin | -2.92 | -2.49 | 0.27 | -0.72 | -2.69 | 0.46 |
| EBITDA | -239.46 Million | -244.24 Million | 169.54 Million | -96.83 Million | -90.33 Million | 92.08 Million |
| Earnings Before Tax Margin | -2.97 | -2.33 | 0.34 | -0.77 | -4.23 | 0.40 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 22.29 Million | 15.62 Million | 22.21 Million | 90.24 Million | 28.91 Million | 19.97 Million |
| Cost of Revenue | 14.63 Million | 8.46 Million | 15.57 Million | 54.53 Million | 12.38 Million | 9.47 Million |
| Gross Profit | 7.66 Million | 7.15 Million | 6.64 Million | 35.7 Million | 16.52 Million | 10.5 Million |
| Operating Expenses | 63.7 Million | 68.92 Million | 70.54 Million | 303.83 Million | 81.48 Million | 83.61 Million |
| Selling, General and Administrative Expenses | 18.85 Million | 18.29 Million | 19.07 Million | - | 23.08 Million | 23.69 Million |
| Research and Development Expenses | 44.81 Million | 50.66 Million | 51.34 Million | - | 58.18 Million | 59.88 Million |
| Other Expenses | -29 Thousand | 34 Thousand | -118 Thousand | -397 Thousand | 220 Thousand | 26 Thousand |
| Cost and Expenses | 78.33 Million | 77.38 Million | 86.11 Million | 358.37 Million | 93.87 Million | 93.08 Million |
| Operating Income | -56.03 Million | -61.76 Million | -63.9 Million | -268.12 Million | -64.96 Million | -73.1 Million |
| Interest Expense | 449 Thousand | 1.97 Million | 1.36 Million | 6.86 Million | 1.62 Million | 1.12 Million |
| Income Tax Expense | - | 1.00 | -152 Thousand | -152 Thousand | -2.74 Million | 1.12 Million |
| Earnings before Tax | -52.98 Million | -63.33 Million | -63.04 Million | -263.64 Million | -61.86 Million | -72.06 Million |
| Net Income | -52.98 Million | -63.33 Million | -62.88 Million | -263.49 Million | -61.86 Million | -72.06 Million |
| Earnings Per Share Basic | -1.05 | -1.38 | -1.43 | - | -1.41 | -1.66 |
| Earnings Per Share Diluted | -1.05 | -1.38 | -1.43 | - | -1.41 | -1.66 |
| Weighted Average Shares Outstanding | 50.6 Million | 45.73 Million | 44 Million | 43.73 Million | 43.94 Million | 43.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 50.6 Million | 45.73 Million | 44 Million | 43.73 Million | 43.94 Million | 43.53 Million |
| Gross Margin | 0.34 | 0.46 | 0.30 | 0.40 | 0.57 | 0.53 |
| EBIT Margin | -2.33 | -3.69 | -2.68 | - | -2.24 | -3.44 |
| Profit Margin | -2.38 | -4.05 | -2.83 | -2.92 | -2.14 | -3.61 |
| EBITDA | -51.98 Million | -57.58 Million | -59.56 Million | - | -64.9 Million | -68.63 Million |
| Earnings Before Tax Margin | -2.51 | -3.95 | -2.88 | -2.97 | -2.25 | -3.66 |
2495
RGL
SOBS
EYE
NL
CTUK